Evaluation of Optical System in the Treatment of - Dry Eye Disease

Inclusion Criteria: * Age 18 years and older of any gender or race. * Provide written informed consent before study participation. * Willingness and ability to return for all study visits. * Ocular Surface Disease Index (OSDI) questionnaire and a score of ≥ 23 at the baseline visit. * Tear break-up time (TBUT) \<10 seconds in both eyes. * Agreement/ability to abstain from dry eye/MGD medications for the time between the treatment visit/s and the final study visit. Ocular lubricants are allowed if no changes are made during the study. Exclusion: * History of ocular surgery including intraocular, oculoplastic, corneal or refractive surgery within 1 year. * Patients with giant papillary conjunctivitis. * Patients with punctal plugs or who have had punctal cautery. * Ocular injury or trauma, chemical burns, or limbal stem cell deficiency within 3 months of the baseline examination. * Active ocular herpes zoster or simplex of eye or eyelid or a history of these within the last 3 months. * Aphakic Patients. * Cicatricial lid margin disease identified via slit lamp examination, including pemphigoid, symblepharon, etc. * Active ocular infection (e.g., viral, bacterial, mycobacterial, protozoan, or fungal infection of the cornea, conjunctiva, lacrimal gland, lacrimal sac, or eyelids including a hordeolum or stye). * Active ocular inflammation or history of chronic, recurrent ocular inflammation within 3 months (e.g., retinitis, macular inflammation, choroiditis, uveitis, iritis, scleritis, episcleritis, keratitis). Criteria: \-